Real-World study reveals how breast cancer patients in brazil use palbociclib
NCT ID NCT05505175
First seen Jun 11, 2026 · Last updated Jun 12, 2026 · Updated 1 time
Summary
This study collected information from 121 women in Brazil with a certain type of advanced breast cancer (HR+/HER2-). Researchers wanted to see how doctors prescribed the drug palbociclib in everyday practice, not in a strict research setting. The goal was to understand patient backgrounds, treatment patterns, and outcomes like how long the cancer stayed under control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centro Especializado de Oncologia de Florianópolis
Florianópolis, 88032-005, Brazil
-
Centro de Tratamento de Tumores Botafogo
Rio de Janeiro, 22.250-905, Brazil
-
Ensino E Terapia de Inovação Clínica Amo - Ética
Salvador, Estado de Bahia, 41.830-492, Brazil
-
Hcor - Associação Beneficente Síria
São Paulo, 04004-030, Brazil
-
Hospital Araújo Jorge
Goiânia, Goiás, 74605-070, Brazil
-
Hospital Paulistano - INSTITUTO DE EDUCAÇÃO, PESQUISA E GESTÃO EM SAÚDE
São Paulo, 01323-000, Brazil
-
Hospital Sírio Libanês
Brasília, Federal District, 70200-730, Brazil
-
Instituto D'or de Pesquisa e Ensino
Recife, 50070-480, Brazil
-
Instituto D´Or de Pesquisa E Ensino - Brasília
Brasília, Federal District, 70.390-700, Brazil
-
Instituto D´or de Pesquisa e Ensino
Rio de Janeiro, 22281-100, Brazil
-
Instituto de Educação, Pesquisa e Gestão em Saúde
Rio de Janeiro, 22793-080, Brazil
-
Instituto de Mastologia e Oncologia
Goiânia, 74110-060, Brazil
-
NOB - Nucleo de Oncologia da Bahia
Salvador, Estado de Bahia, 40170-110, Brazil
-
Oncoclínicas Do Brasil Servicos Médicos S/A - Oncocentro
Belo Horizonte, Minas Gerais, 30.360-680, Brazil
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.